TSPAN 33 IS A CANDIDATE FOR ANTIBODY TARGETED THERAPY FOR THE TREATMENT OF B CELL HODGKIN LYMPHOMAS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP13864754.0

公开号：

EP2934586A2

申请日:

2013.12.20

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

A method of treating a disease associated with activated B lymphocytes expressing Tetraspanin 33 (TSPAN33/BAAM). The disease can be, for example, lymphoma or an immune disease. The method includes administering an anti-TSPAN33/BAAM antibody to a patient in need of such treatment in an amount effective to treat the disease. Methods of purifying activated B cells and identifying activated and/or diseased B cells are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/